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Background: Problem alcohol use is common among illicit drug users and is associated with adverse health
outcomes. It is also an important factor in poor prognosis among drug users with hepatitis C virus (HCV) as it
impacts progression to hepatic cirrhosis or opiate overdose in opioid users. The aim of this systematic review was
to assess the effects of psychosocial interventions for problem alcohol use in adult illicit drug users with concurrent
problem alcohol use (principally, problem drug users of opiates and stimulants).
Methods: We searched the following databases (November 2011): Cochrane Library, PUBMED, EMBASE, CINAHL,
PsycINFO and reference list of articles. We also searched conference proceedings and online registers of clinical
trials. Two reviewers independently assessed risk of bias and extracted data from included randomized controlled
trials.
Results: Four studies (594 participants) were included in this review. Half of the trials were rated as having a high
or unclear risk of bias. The four studies considered six different psychosocial interventions grouped into four
comparisons: 1) cognitive-behavioral coping skills training versus 12-step facilitation (N = 41), 2) brief intervention
versus treatment as usual (N = 110), 3) hepatitis health promotion versus motivational interviewing (N = 256), and
4) brief motivational intervention versus assessment-only group (N = 187). Differences between studies precluded
any pooling of data. Findings are described for each trial individually. Most findings were not statistically significant
except for comparison 2: decreased alcohol use at three months (risk ratio (RR) 0.32; 95% confidence interval (CI)
0.19 to 0.54) and nine months (RR 0.16; 95% CI 0.08 to 0.33) in the treatment-as-usual group and comparison
4: reduced alcohol use in the brief motivational intervention (RR 1.67; 95% CI 1.08 to 2.60).
Conclusions: No conclusion can be made because of the paucity of the data and the low quality of the retrieved
studies.
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Problem alcohol use is common among illicit drug users
and is associated with adverse health outcomes, which
include physical, psychological and social implications
[1-4]. Recent NIDA (National Institute on Drug Abuse)
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reproduction in any medium, provided the ordisorders (AUDs) in 38% and 45% of opiate- and stimulant-
using treatment seekers, respectively [5,6].
Problem drug users are at high risk of liver disease
resulting from hepatitis C virus (HCV) infection because
of its high prevalence in this population [7]. Problem
alcohol use is an important factor in determining poor
prognosis among people with HCV as it impacts pro-
gression to hepatic cirrhosis, increased HCV-ribonucleic
acid (RNA) levels or fatal opiate overdose in opiate users
[8,9].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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‘psychologically-based interventions aimed at reducing
consumption behavior or alcohol-related problems’ [10],
which exclude any pharmacological treatments. The
most frequently used interventions include motivational
interviewing (MI), cognitive-behavioral therapy (CBT),
psychodynamic approaches, screening and brief inter-
ventions (SBI), family therapy, drug counseling, 12-step
programs, therapeutic communities (TC) and vocational
rehabilitation (VR). For descriptions, see the review by
Amato et al. [11].
Substantial evidence has described the value of psy-
chosocial interventions in treating problem alcohol use
[12-15]. Even in their brief version, psychosocial inter-
ventions are feasible and potentially highly effective
components of an overall public health approach to
reducing problem alcohol use, although considerable
variation in effectiveness trials exists and problem drug
users from non-specialist settings (for example, primary
care) are under-represented in these trials [10,16].
Two previous narrative reviews of literature have dealt
with the question being asked in this review, to date.
The older of these reviews discussed six reports of four
studies among methadone patients and saw some pro-
mise in the contingency management procedures [17]. A
more recent review described implications of combining
behavioral and pharmacological treatments that are
effective in treating either alcohol- or drug-use disorders
alone, for the treatment of people who have both of
these disorders [18]. While pointing to the paucity of re-
search specifically focused on the treatment of people
with co-occurring alcohol and other substance use disor-
ders, the reviews concluded that successful treatment
must take into account both alcohol- and drug-use
disorders.
The lack of systematic evaluation, together with the
anticipated differences in the responsiveness of problem
drug users to psychosocial interventions, provides add-
itional reasons for conducting this review [19].
Objective
This article provides a comprehensive summary of the 62-
page systematic review assessing interventions for prob-
lem alcohol use in illicit drug users, published in the
Cochrane Library [20]. The aim of the systematic review
was to determine the effectiveness of psychosocial inter-
ventions targeting problem alcohol use versus other treat-
ments in illicit drug users, especially the effectiveness of
these interventions on reducing alcohol consumption.
Methods
Searching and study selection
Only studies that defined participants as adult (≥ 18
years) problem drug and alcohol users at randomizationwere included. Problem drug use was defined by the
European Monitoring Centre for Drugs and Drug Addic-
tion as ‘injecting drug use or long-duration/regular use
of opioids, cocaine and/or amphetamines’ [21]. The con-
sidered interventions were any psychosocial interven-
tions described by the study’s author as such (for
example, motivational interviewing, brief intervention,
cognitive behavioral therapy, contingency management,
family therapy, etcetera).
The outcomes assessed were 1) alcohol use (reduction
or stabilization) as measured by either biological mar-
kers or self-report tests; 2) illicit drug use (changes in
illicit drug use) as measured by either biological markers
or self-report tests; 3) engagement in further treatment
(that is, drop-out rates, utilization of health services);
4) alcohol-related problems or harms as represented by
physical or mental health outcomes associated with
problem alcohol use. We planned to pool the results
from individual trials if a sufficient number of studies
used a measure of alcohol problems and the included
studies utilized similar instruments to measure their
outcomes.
An all-language search (November 2011) identified
trials in MEDLINE (since 1966), CINAHL (since 1982),
The Cochrane Library, (Issue 11, Nov 2011), PsycINFO
(since 1872), and EMBASE (since 1974). Databases were
searched using a strategy developed incorporating the
filter for the identification of RCTs [22], combined with
selected MeSH terms and free-text terms relating to alco-
hol use (See search strategy in Table S6, Additional file 1).
We also searched reference lists of articles considered
eligible based on full report screening and other relevant
papers; conference proceedings; controlled trial registers;
and contacted investigators and relevant trial authors
seeking information about unpublished or incomplete
trials.
Included studies were randomized controlled trials
(RCTs) or clinical trials (CCTs) that compared psycho-
social intervention to other psychosocial interventions,
standard care, no intervention, waiting list, placebo/or
any other non-pharmacological therapy (including mo-
derate drinking, assessment only). Multiple-arm trials
were included if they had at least two psychosocial arms.
Data extraction and analysis
Two authors screened lists of citations and abstracts in-
dependently. Differences between selection lists were
resolved by discussion with two other review authors
with respective thematic and methodological expertise.
Full texts of all potentially relevant records were
retrieved and data were extracted independently by two
authors from the full-text reports, using an electronic
version of an amended data extraction form of the
Cochrane Drug and Alcohol review group (CDAG).
Klimas et al. Systematic Reviews 2013, 2:3 Page 3 of 7
http://www.systematicreviewsjournal.com/content/2/1/3Quality assessments were performed independently by
two authors using the criteria recommended by the
Cochrane Handbook for Systematic Reviews of Interven-
tions [22]: the domains of sequence generation, alloca-
tion concealment blinding of outcome assessor
(separately for objective and subjective outcomes) and
incomplete outcome data (end of the study and results
at follow-up).
A formal meta-analysis was not possible owing to sub-
stantial differences between studies; there were no two
studies similar enough to be considered for pooling.
Results of included studies are reported individually for
each trial, re-expressed as RRs for dichotomous out-
comes and MDs for continuous outcomes, and reported
with 95% Confidence Intervals (CIs). A fixed-effect
model was used because there was only one study for
each comparison.Ethical considerations
This systematic review adheres to the Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines [23].Figure 1 Flow chart for studies in the systematic review.Results
Study flow, trial characteristics, and quality assessment
The process and results of study identification are out-
lined in a flow diagram (Figure 1) according to the
PRISMA statement [23].
Four studies (594 participants) were eligible for this re-
view. The studies assessed the effectiveness of six psy-
chosocial interventions: CBT, 12-step facilitation (TSF),
BI, hepatitis health promotion (HHP), MI, and brief mo-
tivational intervention (BMI).
The types of psychosocial intervention and setting are
as follows:
1. CBT versus TSF in an outpatient clinic [24].
2. BI versus treatment as usual in an outpatient clinic
with/without opioid substitution treatment [25].
3. MI (group) versus HHP in an opioid substitution
clinic [26].
4. MI (single) versus HHP in an opioid substitution
clinic [26].
5. BMI versus assessment only in a needle exchange
program [27].
Three studies were conducted in USA and one study
was conducted in Switzerland. Trial duration ranged
from 4 to 12 weeks (plus various follow-ups) with a
mean duration of 7.5 weeks. Between one and 16 ses-
sions were offered to participants, with a mean of 5.5
sessions being offered (from 15 minutes to 16 hours of
treatment time).Of the 594 participants, all were problem drug usersb.
Thirty-three percent of the participants were female.
Mean age was 38.3 years.
See Characteristics of included studies table in Table S7,
Additional file 2 for more detailed information. Methodo-
logical quality of the included studies was generally
considered as low. Random sequence generation was
judged as adequate in two studies, while only one study
was judged being at a low risk of bias, one was judged
at a high risk of bias and the remaining at an unclear
risk of bias. Participants and personnel were not
blinded in all studies to the kind of interventions
involved, and objective outcomes were not reported in
the trials. They were used as an additional measure to
confirm abstinence in two studies.
For subjective outcomes, participants and personnel
were not blinded in all studies to the kind of interven-
tions; two studies (50%) specified that outcome assessors
were blinded and were judged to be at low risk of bias.
Two studies reported that the outcome assessor was not
blinded and were judged at a high risk of bias; for one of
Table 1 Cognitive-behavioral coping skills training (CBT) versus 12-step facilitation (TSF)
Outcome or subgroup Studies Participants Statistical method Effect estimate
1.1 Continuous outcomes Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.1.1 Alcohol abstinence as maximum number of weeks of
consecutive alcohol abstinence during treatment
1 41 Mean Difference (IV, Fixed, 95% CI) 0.40 [-1.14, 1.94]
1.1.2 Illicit drug abstinence as maximum number of weeks of
consecutive abstinence from cocaine during treatment
1 41 Mean Difference (IV, Fixed, 95% CI) 0.80 [-0.70, 2.30]
1.2 Dichotomous outcomes Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.2.1 Alcohol abstinence as number achieving three or more weeks
of consecutive alcohol abstinence during treatment
1 41 Risk Ratio (M-H, Fixed, 95% CI) 1.96 [0.43, 8.94]
1.2.2 Illicit drug abstinence as number achieving three or more
weeks of consecutive abstinence from cocaine during treatment
1 41 Risk Ratio (M-H, Fixed, 95% CI) 1.10 [0.42, 2.88]
1.2.3 Alcohol abstinence during follow-up year 1 41 Risk Ratio (M-H, Fixed, 95% CI) 2.38 [0.10, 55.06]
1.2.4 Illicit drug abstinence as abstinence from cocaine during
follow-up year
1 41 Risk Ratio (M-H, Fixed, 95% CI) 0.39 [0.04, 3.98]
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munication with the study authors. For incomplete out-
come data, three studies were judged to be at low risk of
bias because only a few patients (less than 10%) with-
drew from the studies, or inversely there was a high rate
of drop-out, but percentages were balanced across inter-
vention groups and reasons for withdrawing were pro-
vided, or authors performed an intention to treat (ITT)
analysis. One study was judged to be at a high risk of
bias because of a high drop-out rate, which was unba-
lanced across groups.
Effects of interventions
Meta-analysis of all included studies was not possible
(complete data available from the first author). The
results were summarized according to the type of psy-
chosocial intervention, with comparisons of quantitative
data where possible. The included studies used different
questionnaires to measure their outcomes and for many
of them the authors did not report the post-treatment/
follow-up scores or they did not state what was consid-
ered to represent mild, moderate and severe categories.
This prevented comparison of results across studies.
One study had three arms; in this case they were entered
into two separate comparisons (group and singleTable 2 Brief intervention (BI) versus treatment as usual
Outcome or subgroup Studies
2.1 Continuous outcomes
2.1.1 Alcohol use as AUDIT scores at three months 1
2.1.2 Alcohol use as AUDIT Scores at nine months 1
2.1.3 Alcohol use as number of drinks per week at three months 1
2.1.4 Alcohol use as number of drinks per week at nine months 1
2.2 Dichotomous outcomes
2.2.1 Alcohol use as decreased alcohol use at three months 1
2.2.2 Alcohol use as decreased alcohol use at nine months 1
asignificance P <0.0001.format), so they were not counted twice. Tables 1, 2, 3,
4, 5 below present the effects of the interventions by
comparisons examined in the primary studies. Primary
outcome was alcohol use or abstinence and secondary
outcome was illicit drug use or abstinence.
Most of the comparisons were not statistically signifi-
cant, except for decreased alcohol use at three months
(RR 0.32; 95% CI 0.19 to 0.54) and nine months (RR
0.16; 95% CI 0.08 to 0.35) in the study by Feldman et al.
[25]. These results favored the control intervention.
Also, participants receiving BMI were significantly more
likely to reduce their alcohol use by seven or more days
in the past 30 days at six months, compared to control
group (RR 1.67; 95% CI 1.08 to 2.60) [27].
Discussion
Four studies involving 594 participants were included in
this review. The studies assessed the effectiveness of six
psychosocial interventions: CBT, TSF, BI, HHP, MI, and
BMI. There was significant clinical and methodological
heterogeneity among the included studies, which pre-
cluded meta-analysis. Comparing different psychosocial
interventions, there was only one study for each com-
parison. Most of the comparisons were not statistically
significant, except for decreased alcohol use at threeParticipants Statistical method Effect estimate
Mean Difference (IV, Fixed, 95% CI) Subtotals only
110 Mean Difference (IV, Fixed, 95% CI) 0.10 [-2.96, 3.16]
110 Mean Difference (IV, Fixed, 95% CI) 1.50 [-1.74, 4.74]
110 Mean Difference (IV, Fixed, 95% CI) 2.40 [-4.59, 9.39]
110 Mean Difference (IV, Fixed, 95% CI) −1.70 [-8.93, 5.53]
Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
110 Risk Ratio (M-H, Fixed, 95% CI) 0.32a [0.19, 0.54]
110 Risk Ratio (M-H, Fixed, 95% CI) 0.16a [0.08, 0.33]
Table 3 Motivational interviewing (group) (MI-G) versus hepatitis health promotion (HHP)
Outcome or subgroup Studies Participants Statistical method Effect estimate
3.1 Continuous outcomes Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1.1 Alcohol use as number of standard drinks consumed per day
over the last 30 days
1 147 Mean Difference (IV, Fixed, 95% CI) −0.40 [-2.03, 1.23]
3.1.2 Illicit drug use as frequency of drug use (as measured by
Addiction Severity Index - ASI drug)
1 147 Mean Difference (IV, Fixed, 95% CI) 0.00 [-0.03, 0.03]
3.1.3 Illicit drug use as a composite drug score (frequency*severity
for all drugs taken)
1 151 Mean Difference (IV, Fixed, 95% CI) 0.0[-0.42, 0.42]
3.2 Dichotomous outcomes Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
3.2.1 Alcohol use as greater than 50% reduction in number of
standard drinks consumed per day over the last 30 days
1 166 Risk Ratio (M-H, Fixed, 95% CI) 1.10 [0.82, 1.48]
3.2.2 Alcohol abstinence as abstinence from alcohol over the
last 30 days
1 166 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.49, 1.58]
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ingly, these results favored the control intervention. This
could be interpreted in light of the main limitations of
this study, namely, the standard intervention provided to
the control group was ‘too strong’ to enable reasonable
comparison with the intervention group, and the inter-
vention group had a high proportion of people with
alcohol addiction who received the 15-minute-long brief
alcohol intervention. This is in contradiction to the
manual for BIs, which states that people with alcohol ad-
diction should not receive BI, but should be referred to
a specialized, more intensive treatment [28]. Also other
systematic reviews examining the general population
indicated that BI was effective for harmful/ hazardous
use, but not for dependence [12,15]. Finally, participants
receiving BMI were significantly more likely to reduce
their alcohol use by seven or more days in the past 30
days at six months’ follow-up, compared to the control
group [27].
Our review was systematic, but not without weak-
nesses. We did not limit our searches to studies pub-
lished in English; however, studies in non-English
languages may have been missed because they are com-
monly less frequently indexed in the selected databases.Table 4 Motivational interviewing (single) (MI-S) versus hepa
Outcome or subgroup Studie
4.1 Continuous outcomes
4.1.1 Alcohol use as number of standard drinks consumed per day
over the last 30 days
1
4.1.2 Illicit drug use as frequency of drug use (as measured by
Addiction Severity Index - ASI drug)
1
4.1.3 Illicit drug use as a composite drug score (frequency/severity
for all drugs taken)
1
4.2 Dichotomous outcomes
4.2.1 Alcohol use as greater than 50% reduction in number of
standard drinks consumed per day over the last 30 days
1
4.2.2 Alcohol abstinence as abstinence from alcohol over the
last 30 days
1Unpublished studies may also have been missed. Unpub-
lished studies are likely to have negative results, which is
why they are not published. The major limitation of the
review process was that most trials did not provide
enough published data or did not provide data in a form
that could be extracted for meta-analysis. Although the
lead authors of all four studies were emailed, only two
responded and provided further data. Furthermore, we
could not include a number of potentially relevant stu-
dies, because they involved drug users without problem
alcohol use in their samples.
Similar to our work, two previous narrative reviews
were unable to identify evidence to answer our question
or to conduct a meta-analysis [17,18]. Subsequently, they
based their conclusions on evidence coming from
mixed-type studies (for example, case studies and RCTs)
or studies that included illicit drug users without a con-
current problem alcohol use. We excluded these types of
studies. Furthermore, the review by Arias et al. [18] dis-
cussed 14 reports/studies related to treatment of co-
occurring alcohol and cocaine/opioid dependence, two
of which were included in our review.
This review is unintentionally tapping into an import-
ant question: what constitutes standard maintenance/titis health promotion (HHP)
s Participants Statistical method Effect estimate
Mean Difference (IV, Fixed, 95% CI) Subtotals only
155 Mean Difference (IV, Fixed, 95% CI) −0.10 [-1.89, 1.69]
155 Mean Difference (IV, Fixed, 95% CI) 0.00 [-0.03, 0.03]
157 Mean Difference(IV, Fixed, 95% CI) −0.10 [-0.46, 0.26]
Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
177 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.68, 1.26]
177 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.56, 1.67]
Table 5 Brief motivational intervention (BMI) versus assessment only
Outcome or subgroup Studies Participants Statistical method Effect estimate
5.1 Continuous outcomes Mean Difference (IV, Fixed, 95% CI) Subtotals only
5.1.1 Alcohol use as number of days in the past 30 days with
alcohol use at one month
1 187 Mean Difference (IV, Fixed, 95% CI) −0.30 [-3.38, 2.78]
5.1.2 Alcohol use as number of days in the past 30 days with
alcohol use at six months
1 187 Mean Difference (IV, Fixed, 95% CI) −1.50 [-4.56, 1.56]
5.2 Dichotomous outcomes Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5.2.1 Alcohol use as 25% reduction of drinking days in the past 30
days
1 187 Risk Ratio (M-H, Fixed, 95% CI) 1.23 [0.96, 1.57]
5.2.2 Alcohol use as 50% reduction of drinking days in the past 30
days
1 187 Risk Ratio (M-H, Fixed, 95% CI) 1.27 [0.96, 1.68]
5.2.3 Alcohol use as 75% reduction of drinking days in the past 30
days
1 187 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [0.84, 1.75]
5.2.4 Alcohol use as one or more drinking days’ reduction in the
past 30 days
1 187 Risk Ratio (M-H, Fixed, 95% CI) 1.12 [0.91, 1.38]
5.2.5 Alcohol use as seven or more drinking days’ reduction in the
past 30 days
1 187 Risk Ratio (M-H, Fixed, 95% CI) 1.67a [1.08, 2.60]
aSignificance P = 0.02.
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ments contain some type of psychosocial support, which
varies considerably, and this makes it difficult to evaluate
the added value of additional services. This was true for
studies included in our review and, in addition, the
process of assessment or quick feedback following the
assessment, or both, resulted in improved alcohol out-
comes among the participants.
Conclusions
Based on the weak evidence identified in this review, we
cannot recommend using or ceasing psychosocial inter-
ventions for problem alcohol use in illicit drug users.
Similar to other conditions, problem alcohol use has bet-
ter prospects for a successful treatment if approached
early. Evidence from the general population suggests that
we need to focus on early detection and intervention as
well as try to influence more established alcohol patterns
of use. Early interventions are not implemented into
routine care, especially in the settings where there is a
potential for impact owing to high exposure, such as pri-
mary care [29-32]. Given the high rates of co-occurrence
of alcohol and drug problems, integration of alcohol-
and drug- orientated interventions appears as a logical
action, but in light of this review remains without an evi-
dence base.
This review emphasizes the need for randomized con-
trolled trials (RCT) to test the effectiveness of psycho-
social interventions in reducing problem alcohol use in
illicit drug users. We recommend RCTs of robust method-
ology that are well reported to allow for critical appraisal.
Endnote
aThis article is an abridged version of a Cochrane
Review recently published in the Cochrane Database ofSystematic Review 2012, Issue 11, DOI: 10.1002/14651858.
CD009269.pub2 (See www.thecochranelibrary.com for in-
formation). Cochrane reviews are regularly updated as new
evidence emerges and in response to feedback. Consult
Cochrane Database of Systematic Reviews for the most
recent version of the review.
bOne multi-arm trial included 122 participants [24];
however, only two psychosocial arms (N = 41) were con-
sidered for this review.Additional files
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